Fundraising FoxNew Vital Signs
Ann Arbor, US · Founded 2015 · Delaware corporation
Find your way into New Vital Signs
Sign up to see every warm intro you have to New Vital Signs
- Paths you didn't know you had: your email and LinkedIn already hold routes to the New Vital Signs team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
New Vital Signs is developing a wearable monitoring platform that measures a new generation of precision vital signs to detect physiologic changes earlier than traditional monitors, aimed at identifying at-risk patients (e.g. sepsis, trauma, heart failure, traumatic brain injury). Its products include DRIVE (respiratory/circulating volume), TOBI (cerebral autoregulation), and VATMOS (peripheral vascular tone), developed in partnership with the University of Michigan Center for Integrative Research in Critical Care.</parameter> <parameter name="founders">[]
Founders & leadership
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2016
▶$1MraisedSep 2016 · 1 investors · BiotechnologyRule 506(b)
- Doug NealExecutive Officer, Director
- Kevin WardDirector
- Dominic SpadaforeExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does New Vital Signs do?
- New Vital Signs is developing a wearable monitoring platform that measures a new generation of precision vital signs to detect physiologic changes earlier than traditional monitors, aimed at identifying at-risk patients (e.g. sepsis, trauma, heart failure, traumatic brain injury). Its products include DRIVE (respiratory/circulating volume), TOBI (cerebral autoregulation), and VATMOS (peripheral vascular tone), developed in partnership with the University of Michigan Center for Integrative Research in Critical Care.</parameter> <parameter name="founders">[]
- How much funding has New Vital Signs raised?
- New Vital Signs has disclosed $1M raised across 1 round.
- Where is New Vital Signs headquartered?
- New Vital Signs is headquartered in Ann Arbor, US.